Avience Biomedicals (NSE:AVIENCE) DeferredTaxAndRevenue: ₹0.0 Mil (As of Jan. 2026)


NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
5 GF Score
Price ₹414.95
View Full Analysis

What is Avience Biomedicals DeferredTaxAndRevenue?

Avience Biomedicals NSE:AVIENCE 5 DeferredTaxAndRevenue is ₹0.0 Mil as of Jan. 2026. GuruFocus rates NSE:AVIENCE with a GF Score™ of 5/100.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Avience Biomedicals's current deferred tax and revenue for the quarter that ended in Jan. 2026 was ₹0.0 Mil.

Avience Biomedicals DeferredTaxAndRevenue Related Terms

Avience Biomedicals DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals DeferredTaxAndRevenue Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
DeferredTaxAndRevenue
0.00 0.00 0.00

Avience Biomedicals Quarterly Data
Mar23 Mar24 Mar25 Jan26
DeferredTaxAndRevenue 0.00 0.00 0.00 0.00
NSE:AVIENCE
5GF Score
Avience Biomedicals Ltd NSE:AVIENCE
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of ₹0.0 Mil mean?
Avience Biomedicals (NSE:AVIENCE) has a DeferredTaxAndRevenue of ₹0.0 Mil as of Jan. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Avience Biomedicals.
Is Avience Biomedicals' DeferredTaxAndRevenue too high?
Avience Biomedicals' current DeferredTaxAndRevenue is ₹0.0 Mil. Overall, Avience Biomedicals has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' DeferredTaxAndRevenue compare to ABT and SYK?
Avience Biomedicals' DeferredTaxAndRevenue of ₹0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Medical Devices & Instruments company?
A good DeferredTaxAndRevenue depends on the Medical Devices & Instruments industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Avience Biomedicals. Avience Biomedicals's current DeferredTaxAndRevenue is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current DeferredTaxAndRevenue of ₹0.0 Mil. The current DeferredTaxAndRevenue is ₹0.0 Mil. Avience Biomedicals' overall GF Score™ is 5/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current DeferredTaxAndRevenue is ₹0.0 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
5GF Score

Get the complete analysis for NSE:AVIENCE

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹414.95
Price